Smith Group Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Sell |
|
|||||
|
2025
Q1 | $570K | Buy |
|
|||||
|
2024
Q4 | $545K | Buy |
|
|||||
|
2024
Q3 | $727K | Buy |
|
|||||
|
2024
Q2 | $485K | Buy |
|
|||||
|
2024
Q1 | $581K | Hold |
|
|||||
|
2023
Q4 | $460K | Buy |
|
|||||
|
2022
Q1 | $241K | Sell |
|
|||||
|
2021
Q4 | $379K | Sell |
|
|||||
|
2021
Q3 | $411K | Sell |
|
|||||
|
2021
Q2 | $500K | Sell |
|
|||||
|
2021
Q1 | $506K | Hold |
|
|||||
|
2020
Q4 | $428K | Sell |
|
|||||
|
2020
Q3 | $590K | Sell |
|
|||||
|
2020
Q2 | $556K | Sell |
|
|||||
|
2020
Q1 | $841K | Buy |
|
|||||
|
2019
Q4 | $322K | Hold |
|
|||||
|
2019
Q3 | $179K | Buy |
|